Endymed Ltd (ENDY.TA)
ILA 320.1
(0.0%)
ILA 320.1
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 553 Thousand USD | -34.94% |
| 2022 | 850 Thousand USD | -83.53% |
| 2021 | 5.16 Million USD | 1575.97% |
| 2020 | 308 Thousand USD | -82.36% |
| 2019 | 1.74 Million USD | -13.61% |
| 2018 | 2.02 Million ILS | 174.82% |
| 2017 | -2.7 Million ILS | 18.4% |
| 2016 | -3.31 Million ILS | 13.58% |
| 2015 | -3.83 Million USD | -7326.42% |
| 2014 | 53 Thousand USD | 114.68% |
| 2013 | -361 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -148 Thousand USD | 67.97% |
| 2024 Q1 | -462 Thousand USD | -310.0% |
| 2023 Q2 | 93 Thousand USD | -86.42% |
| 2023 Q1 | 685 Thousand USD | 55.68% |
| 2023 Q4 | 220 Thousand USD | 149.44% |
| 2023 Q3 | -445 Thousand USD | -578.49% |
| 2023 FY | 553 Thousand USD | -34.94% |
| 2022 Q3 | -220 Thousand USD | -11100.0% |
| 2022 FY | 850 Thousand USD | -83.53% |
| 2022 Q4 | 440 Thousand USD | 300.0% |
| 2022 Q2 | 2000.00 USD | -99.68% |
| 2022 Q1 | 628 Thousand USD | -75.83% |
| 2021 Q4 | 2.59 Million USD | 274.35% |
| 2021 Q1 | 763 Thousand USD | 1059.75% |
| 2021 Q2 | 1.1 Million USD | 45.09% |
| 2021 FY | 5.16 Million USD | 1575.97% |
| 2021 Q3 | 694 Thousand USD | -37.31% |
| 2020 Q3 | -79.5 Thousand USD | -134.05% |
| 2020 Q1 | 233.5 Thousand USD | -69.24% |
| 2020 Q2 | 233.5 Thousand USD | 0.0% |
| 2020 Q4 | -79.5 Thousand USD | 0.0% |
| 2020 FY | 308 Thousand USD | -82.36% |
| 2019 Q2 | 700 Thousand ILS | 579.61% |
| 2019 Q3 | 184 Thousand ILS | -73.71% |
| 2019 FY | 1.74 Million USD | -13.61% |
| 2019 Q4 | 759 Thousand USD | 312.5% |
| 2019 Q1 | 103 Thousand ILS | -85.83% |
| 2018 Q1 | 443 Thousand ILS | 140.27% |
| 2018 FY | 2.02 Million ILS | 174.82% |
| 2018 Q4 | 727 Thousand ILS | 92.33% |
| 2018 Q3 | 378 Thousand ILS | -20.08% |
| 2018 Q2 | 473 Thousand ILS | 6.77% |
| 2017 Q2 | -249 Thousand USD | 70.18% |
| 2017 Q3 | -517 Thousand USD | -107.63% |
| 2017 Q4 | -1.1 Million USD | -112.77% |
| 2017 FY | -2.7 Million ILS | 18.4% |
| 2017 Q1 | -835 Thousand USD | 13.11% |
| 2016 Q2 | -938 Thousand USD | 15.42% |
| 2016 Q3 | -302 Thousand USD | 67.8% |
| 2016 FY | -3.31 Million ILS | 13.58% |
| 2016 Q4 | -961 Thousand USD | -218.21% |
| 2016 Q1 | -1.1 Million USD | 31.67% |
| 2015 FY | -3.83 Million USD | -7326.42% |
| 2015 Q4 | -1.62 Million USD | -68.54% |
| 2015 Q3 | -963 Thousand USD | -91.07% |
| 2015 Q2 | -504 Thousand USD | 31.89% |
| 2015 Q1 | -740 Thousand USD | -398.39% |
| 2014 Q2 | -352 Thousand USD | 7.12% |
| 2014 Q1 | -379 Thousand USD | -98.22% |
| 2014 FY | 53 Thousand USD | 114.68% |
| 2014 Q4 | 248 Thousand USD | -58.87% |
| 2014 Q3 | 603 Thousand USD | 271.31% |
| 2013 FY | -361 Thousand USD | 0.0% |
| 2013 Q2 | -136.41 Thousand USD | 31.3% |
| 2013 Q3 | 164.46 Thousand USD | 220.57% |
| 2013 Q4 | -191.19 Thousand USD | -216.25% |
| 2013 Q1 | -198.55 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|